Published • loading... • Updated
CU Anschutz–Led Team Publishes National Roadmap for First Approved Immunotherapy for Newly Diagnosed Type 1 Diabetes in Children
Summary by cuanschutz.edu
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
CU Anschutz–Led Team Publishes National Roadmap for First Approved Immunotherapy for Newly Diagnosed Type 1 Diabetes in Children
For the first time, children ages 8 to 17 who are newly diagnosed with type 1 diabetes have access to an approved treatment that targets the underlying autoimmune disease, rather than solely managing blood sugar levels with insulin.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
